Increased expression levels of the liver residing fatty acid binding protein (Fabp1, Q3V2F7) indicate an active PPAR pathway [12] which, in turn, initiates adipose cell differentiation ultimately resulting in NAFLD [13]. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.